| abstract |
Compositions, kits, and methods for treatment of cancers are generally provided. In some embodiments, the compositions, kits, and methods comprise a platinum (e.g., Pt (II) or Pt (IV)) compound associated with a ligand (e.g., a beta-diketonate ligand) comprising a targeting moiety. Methods of synthesizing platinum (e.g., Pt (II) or Pt (IV)) compounds associated with a ligand comprising a targeting moiety are also provided. |